primary clinical study of ct- guided iodine-125 seed implantation therapy in patients with advanced...

44
Primary Clinical Study of CT-guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上上上上上上上上上上上上上上上上上上上 上上上

Upload: elfreda-mccormick

Post on 03-Jan-2016

321 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Primary Clinical Study of CT-guided Iodine-125 Seed Implantation Therapy in Patients with Advanced

Pancreatic Cancer

上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Page 2: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Brachytherapy

1898 年居里夫人发现镭

1905 年即进行了第 1 例镭针插管治疗

1930 年 Paterson 及 Parker 建立了曼切斯特( Manchester )系统

1935 年小居里夫妇发现了人工放射性同位素

80 年代中期,现代近距离治疗迅速发展

Page 3: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

生物学优势(外放疗相比)

• 肿瘤局部治疗的持续时间长• 放射治疗的剂量较低• 对周围正常组织的损伤小• 对肿瘤细胞的杀伤力强

Page 4: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Implant radioactive seeds into tumors

Emit continueous low energy γ rays

Injury of tissues and cellsCell death and mutation

leading to cancer

Interact with biomacromolecule

Page 5: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Animal experiment

Clinical research

Page 6: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Human pancreatic cancer Sw1990 cell

BABL/c was inoculated into the dorsal side of right lower extremity inguinal region of nude mice

Passaged for 3 tims subcutaneously, initiate the experiments after tumor formation was stablized

Experimental designExperimental design

Page 7: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Subcutaneous pancreatic cancer xenograft in nude mice

Seed implantation group

Control group

Experimental methodExperimental method

Page 8: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Change of xenograft volume in nude mice

Page 9: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Comparison of tumor inhibition rate

Page 10: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏
Page 11: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Obvious liquefaction necrosis can be seen in the centeral area of Experimental group tumor, there are sparse cells aroud the necrosis area (×100)

HE staining

There is no or little necrosis area in center of control group tumor, there are multiple tumor cells (×100)

Page 12: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Experimental group positive TK1 staining cells are exiguous ( ×200 )

Control group positive TK1 staining cells are abundent ( ×200 )

HE staining

Page 13: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏
Page 14: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

碘 -125 放射粒子组织间植入治疗属放射治疗, 对周围正常器官组织无明显放射损伤

裸鼠移植瘤组织植入碘 -125 粒子后,实验组心、 肺、肝、肾、脾脏外观大致正常,病理检查未 见明显放射性炎症表现

Preliminary resultPreliminary result

Page 15: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

ZM. Wang MD, Shanghai Ruijin Hospital

Introduction

Pancreatic cancer is a devastating disease

and the prognosis remains poorFew patients are eligible for curative surgical

resectionAlternative therapeutic options are in demand

Page 16: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Traditional therapy vs. External irradiation therapy vs. percutaneous

seed implantation

ZM. Wang MD, Shanghai Ruijin Hospital

Page 17: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

External irradiation therapy was regarded as insensitive to pancreatic cancer and associated with more systemic side effects

Radioactive iodine-125 seed implantation has minimal surgical trauma and few complications

The most commonly used isotope is iodine-125125I placement was routinely used at our institution for

recurrent tumors at various sitesThe aim of this study was to test its feasibility for

pancreatic lesions

Current Controversies

Page 18: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

11th IO 2010, May 23

Methods and materials

Patient populationo December 2004 to August 2007, 31 consecutive patients

were included in this prospective, nonrandomized study o Patients were diagnosed by CT or MRI with histological

confirmation of the diagnosis by FNAo All patients enrolled displayed contraindications to

surgery or had rejected surgical treatment due to personal reasons

Page 19: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

ZM. Wang MD, Shanghai Ruijin Hospital

Methods and materials

The total volume of each tumor was calculated with the treatment planning system (TPS) before implantationThe expected number of implanted seed was calculated according to the modified level formulaPatients were kept in our radiooncology/interventional ward with an usual stay of 4 full days

Page 20: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Methods and materials

Clinical benefit response was derived from measurement of pain, functional impairment and weight loss

Patients were examined by CT after the operationResponse rate was defined as the sum of CR and

PR Local tumor control was defined as the absence of

tumor progression (SD+PR+CR)

Page 21: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Methods and materials

10 patients received concurrent chemotherapy with arterial infusion of gemcitabin and 5-fluorouracil (5-Fu)

Chemotherapy was initiated one week after and repeated up to four cycles

Follow-up visits at 1 month, 3 month, and every 3 months for clinical examination, blood sampling, and CT examination

ZM. Wang MD, Shanghai Ruijin HospitalZM. Wang MD, Shanghai Ruijin Hospital

Page 22: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

适应症

• 实体瘤(如前列腺癌)的根治性治疗• 实体瘤术后残余组织的预防性治疗• 转移性肿瘤病灶或术后孤立性肿瘤转移灶而失去

手术价值者• 无法手术的原发肿瘤的姑息性治疗

Page 23: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

禁忌证

• 放射性治疗不宜 ( 如血液病等 ) 及有麻醉禁忌等• 病灶范围广泛• 恶液质、全身衰竭• 肿瘤部位有活动性出血、坏死或溃疡• 严重糖尿病

Page 24: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Iodine-125 Therapy in Advanced Pancreatic Cancer

Results

Change of Karnofsky physical score % (cases)

Karnofsky score

100 90 80 70 60 50

Pre-op 0 ( 0/31 ) 3.2 ( 1/31 )

9.7(3/31) 41.9(13/31) 35.5(11/31) 9.7 ( 3/31 )

Post-op 0 ( 0/31 ) 48.4(15/31) 16.1(5/31) 9.7(3/31) 19.4(6/31) 6.4(2/31)

Page 25: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Results

Change of pain score % (cases)

Iodine-125 Therapy in Advanced Pancreatic CancerIodine-125 Therapy in Advanced Pancreatic Cancer

No Pain (%) Mild Pain (%) Moderate Pain (%)

Severe Pain (%)

Pre-op 6.5 ( 2/31 ) 22.5(7/31) 32.3(10/31) 38.7(12/31)

Post-op 38.7(12/31) 32.3(10/31) 16.1(5/31) 12.9(4/31)

Page 26: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Results

Overall responding rate (CR+PR) =61.3% Local tumor control rate was 90.3%Median survival time for the whole group was 10.31 monthsMedian survival time for pure seeds implantation (21 cases) was 7 monthsmedian survival time for drug-seeds combined was 11 month

Page 27: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Pre-implant CT scan (Case one)

ZM. Wang MD, Shanghai Ruijin Hospital

Page 28: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Post-implant CT scan

ZM. Wang MD, Shanghai Ruijin Hospital

Page 29: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Pre-implant CT scan (Case Two)

Page 30: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

术后 CT 扫描术中穿刺碘粒子植入

Post-implant CT scan

Page 31: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Post-implant CT scan

Page 32: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

病例 2 男性 76 岁 胰腺癌(胰体尾部)

Pre-implant CT scan (Case Three)

Page 33: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

术后 CT 扫描

Post-implant CT scan

Page 34: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Pre-implant CT scan (Case Four)

Page 35: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Post-implant CT scan

术后 CT 二维重建

Page 36: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Post-implant CT scan

Page 37: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Complications

No serious complications encountered 2 seeds of radioactive 125I found to migrate

to liver in 2 patients Leukopenia and renal function impairment

were found in 4 patients of drug-seeds

combination group

Iodine-125 Therapy in advanced Pancreatic Cancer

Page 38: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

DiscussionPercutaneous image-guided seed implantation

has attracted increasing attentionExtensive experiences with this technique had

been collected targeting liver and lung

malignanciesThe most commonly used isotope is 125I , and 125I placement has become a routine treatment

for recurrent tumors at various sites in our

institution ZM. Wang MD, Shanghai Ruijin Hospital

Page 39: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Technical points during the procedure

Patients fasted for 24 hoursEnsure steady breath movement during the procedurePancreatic secretion was inhibitedTransgress stomach is safer than intestine, avoiding colon especially when using large-bore needlesFor patients with jaundice, do PTCD firstImmediate CT scan post implantation was done to verify the distribution of the seeds

ZM. Wang MD, Shanghai Ruijin Hospital

Page 40: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Drug-seeds combined therapy

There is data suggests that local control rates

can be enhanced by the addition of

chemotherapyIn our study the median survival time between

the two groups reached statastically

significant and encouraged further evaluation

ZM. Wang MD, Shanghai Ruijin Hospital

Page 41: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Conclusions

This study suggested that CT-guided brachytherapy using 125I seeds implantation appeared to be safe, effective, less complicated and could produce adequate pain relief for treating unresectable pancreatic cancer

 Iodine-125 Therapy in Advanced Pancreatic Cancer

Page 42: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

国内临床尚有许多问题需要解决 • 临床应用适应症选择标准不一,造成不同医院应用放射

性粒子植入治疗技术后疗效评价缺乏标准,尤其在放射性粒子治疗肿瘤的过程中,现在面临的缺乏行业管理标准和操作技术规范

• 如不同增殖速率的肿瘤如何选择不同放射性核素 , 以获得最大的杀伤效应

• 粒子种植治疗仍是局部治疗手段,是外科和外放疗的补充和延伸,单纯放射性粒子植入治疗并不能解决所有肿瘤治疗问题,如何合理、科学地与外科、外放疗和化疗结合,最大限度发挥粒子植入治疗的优势

Page 43: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

展 望

• 由于放射性粒子植入治疗恶性肿瘤创伤小,靶区剂量分布较均匀和对周围正常组织损伤较小等特点,在临床应用展现了广阔的前景

• 同样放射性粒子植入技术治疗肿瘤需要多学科联合,特别需要准确的治疗计划、娴熟的治疗技术和严谨的术后质量评估

Page 44: Primary Clinical Study of CT- guided Iodine-125 Seed Implantation Therapy in Patients with Advanced Pancreatic Cancer 上海交通大学医学院附属瑞金医院卢湾分院 王忠敏

Thanks for your attentionThanks for your attention